A Multi-Institutional Phase II Trial of Ablative 5-Fraction Stereotactic MR-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
暂无分享，去创建一个
P. Parikh | A. Raldow | J. Mancias | D. Levin | M. Fuss | L. Boldrini | P. Kelly | K. Padgett | C. Glide-Hurst | Yingli Yang | L. Portelance | Adam C Mueller | M. Bassetti | L. Henke | C. Williams | Joshua Kim | L. Placidi | Rongxiao Zhang | B. Zaki | K. Mooney | M. Chuong | K. Mittauer | M. Pfeffer | A. Price | Hyun Kim | J. Ng | R. Pennell | P. Lee | A. Shah | D. Low